ENVERIC BIOSCIENCES INC (ENVB) Stock Analyst Earnings Estimates
NASDAQ:ENVB - Nasdaq - US29405E2081 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 48.59M 34.41% | 43M -11.50% | 39.91M -7.19% | N/A -100.00% | 15.3M | 25.5M 66.67% | 51M 100.00% | 69.666M 36.60% | 149.43M 114.49% | |||||||
| EBITDA YoY % growth | -7.2M -196.30% | 5.12M 171.11% | -4.05M -179.10% | N/A -35.80% | N/A -348.00% | N/A 20.29% | -15.096M 18.00% | -13.974M 13.23% | -6.12M 56.20% | N/A | -8.058M | -816K 89.87% | 19.584M 2,500.00% | 26.112M 33.33% | 85.884M 228.91% | |
| EBIT YoY % growth | -10.42M -174.93% | 2.22M 121.31% | -6.32M -384.68% | N/A 11.08% | -18.009M -350.00% | -21.132M 21.04% | -18.634M 17.63% | -18.339M -11.49% | -19.901M -8.52% | -22.514M -13.13% | -11.118M 50.62% | -4.284M 61.47% | 15.708M 466.67% | 21.114M 34.42% | 80.274M 280.19% | |
| Operating Margin | -21.44% | 5.16% | -15.84% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -72.67% | -16.80% | 30.80% | 30.31% | 53.72% | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | -26.01 | -12.71 51.14% | -8.33 34.43% | -2.12 74.54% | -1.44 32.21% | -1.79 -24.11% | N/A | N/A | N/A | N/A | N/A |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.41 72.24% | -0.41 33.11% | -0.36 90.48% | -0.36 90.08% | -0.32 22.50% |
| Revenue Q2Q % growth | N/A | N/A | N/A | N/A | |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -3.60 -176.92% | -7.96 | 4.36 | 54.75% |
| Q2 2024 Q2Q % growth | -3.75 -23.36% | -8.42 | 4.67 | 55.44% |
| Q1 2024 Q2Q % growth | -0.61 80.07% | -0.79 | 0.18 | 22.83% |
| Q4 2023 Q2Q % growth | -1.47 66.09% | -1.58 | 0.11 | 6.72% |
| Q3 2023 Q2Q % growth | -1.30 47.37% | -2.13 | 0.83 | 39.02% |
| Q2 2023 Q2Q % growth | -3.04 -11.36% | -0.66 | -2.38 | -358.52% |
| Q1 2023 Q2Q % growth | 42.80% | -3.06 | % | |
| Q4 2022 Q2Q % growth | 95.13% | -4.34 | % | |
| Q3 2022 Q2Q % growth | -2.47 58.83% | -4.08 | 1.61 | 39.46% |
| Q2 2022 Q2Q % growth | -2.73 -36.50% | -3.91 | 1.18 | 30.18% |
| Q1 2022 Q2Q % growth | -5.35 -2,575.00% | -6.12 | 0.77 | 12.58% |
| Q4 2021 Q2Q % growth | -89.00 | -8.16 | -80.84 | -990.69% |
| Q3 2021 Q2Q % growth | -6.00 | -8.16 | 2.16 | 26.47% |
| Q2 2021 Q2Q % growth | -2.00 | -8.93 | 6.93 | 77.59% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2020 Q2Q % growth | -100.00% | % | ||
| Q3 2020 Q2Q % growth | -100.00% | % | ||
| Q2 2020 Q2Q % growth | -100.00% | % | ||
| Q1 2020 Q2Q % growth | -100.00% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 18.37% | 0% | 0% |
| Revenue | N/A | N/A | N/A | N/A |